GLAUCOMA--NEW DRUGS AND MECHANISMS OF AQUEOUS SECRETION

青光眼--新药和水液分泌机制

基本信息

  • 批准号:
    3256605
  • 负责人:
  • 金额:
    $ 28.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1978
  • 资助国家:
    美国
  • 起止时间:
    1978-03-01 至 1995-02-28
  • 项目状态:
    已结题

项目摘要

The proposed work is divided into four related categories, all converging on the problems of aqueous humor formation and treatment of glaucoma: Development of new drugs (topical carbonic anhydrase inhibitors); study of ionic reactions underlying secretion of aqueous; exploration of the effect of A1C13 and other acids on aqueous secretion and pH of ciliary processes; effect of autonomic drugs and Na-K-ATPase inhibitors on electrolyte movement from plasma to aqueous. 1.) We are searching for a topical carbonic anhydrase inhibitor with properties such that 1 drop of solution will lower intraocular pressure in man for 6-12 hours. This demands a continuing effort in organic synthesis, analysis of physico-chemical properties of compounds, and aqueous humor dynamics in animals and man. Feasibility of this goal seems reasonable; it has already been achieved in the rabbit. Almost certainly, such a compound will have no systemic toxicity in man, or any other effect on the eye. 2.) We believe it possible (likely?) that in aqueous humor (and other secretory sites, as cerebrospinal fluid and pancreas), the observed linkage of Na+ and HCO3- has a specific chemical basis, in ion pairing of NaCO3- and NaHCO3-degrees. This has not been considered for epithelial secretion but has been entertained as a basis for HCO3- - Cl- exchange in red cells. In this view Na+ is not the moving force for fluid formation, but Na is incorporated into an anion or undissociated molecule. We shall investigate this; if true, the new concept should profoundly affect studies of ion transport. 3.) We continue to study our finding that protonation by Lewis or Bronsted acids reduces or abolishes aqueous humor secretion. This has theoretical implications for mechanisms of secretion and offers the possibility of reduction of aqueous secretion by new methods. In this context we shall also study the pH of ciliary process and how this may be changed by acids or by carbonic anhydrase inhibitors. 4.) We shall measure the rates of ion movement from plasma to aqueous humor, before and after administration of various classes of drugs known to affect aqueous secretion, as we have done with carbonic anhydrase inhibitors. This is a neglected aspect of ocular pharmacology; we shall study ouabain, timolol, pilocarpine, epinephrine, and several others. Such measurements should throw light on their (presently unknown) mechanism.
建议的工作分为四个相关的类别,所有类别都是相互衔接的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS H MAREN其他文献

THOMAS H MAREN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS H MAREN', 18)}}的其他基金

GLAUCOMA--NEW DRUGS AND MECHANISMS OF AQUEOUS SECRETION
青光眼--新药和水液分泌机制
  • 批准号:
    3256599
  • 财政年份:
    1978
  • 资助金额:
    $ 28.45万
  • 项目类别:
GLAUCOMA--NEW DRUGS AND MECHANISMS OF AQUEOUS SECRETION
青光眼--新药和水液分泌机制
  • 批准号:
    3256603
  • 财政年份:
    1978
  • 资助金额:
    $ 28.45万
  • 项目类别:
GLAUCOMA--NEW DRUGS AND MECHANISMS OF AQUEOUS SECRETION
青光眼--新药和水液分泌机制
  • 批准号:
    3256604
  • 财政年份:
    1978
  • 资助金额:
    $ 28.45万
  • 项目类别:
GLAUCOMA--NEW DRUGS AND MECHANISMS OF AQUEOUS SECRETION
青光眼--新药和水液分泌机制
  • 批准号:
    2158384
  • 财政年份:
    1978
  • 资助金额:
    $ 28.45万
  • 项目类别:
NEW PHARMACOLOGY ASPECTS RELATED TO CARBONIC ANHYDRASE
与碳酸酐酶相关的新药理学方面
  • 批准号:
    3336804
  • 财政年份:
    1978
  • 资助金额:
    $ 28.45万
  • 项目类别:
GLAUCOMA--NEW DRUGS AND MECHANISMS OF AQUEOUS SECRETION
青光眼--新药和水液分泌机制
  • 批准号:
    3256601
  • 财政年份:
    1978
  • 资助金额:
    $ 28.45万
  • 项目类别:
GLAUCOMA--NEW DRUGS AND MECHANISMS OF AQUEOUS SECRETION
青光眼--新药和水液分泌机制
  • 批准号:
    3256602
  • 财政年份:
    1978
  • 资助金额:
    $ 28.45万
  • 项目类别:
NEW PHARMACOLOGY ASPECTS RELATED TO CARBONIC ANHYDRASE
与碳酸酐酶相关的新药理学方面
  • 批准号:
    3336805
  • 财政年份:
    1978
  • 资助金额:
    $ 28.45万
  • 项目类别:
GLAUCOMA-NEW DRUGS AND MECHANISMS OF AQUEOUS SECRETION
青光眼-新药和水液分泌机制
  • 批准号:
    3256606
  • 财政年份:
    1978
  • 资助金额:
    $ 28.45万
  • 项目类别:
GLAUCOMA--NEW DRUGS AND MECHANISMS OF AQUEOUS SECRETION
青光眼--新药和水液分泌机制
  • 批准号:
    3256598
  • 财政年份:
    1978
  • 资助金额:
    $ 28.45万
  • 项目类别:

相似海外基金

Cooperating Autonomic Agents for Management of Complex Systems
协作自主代理管理复杂系统
  • 批准号:
    RGPIN-2022-04521
  • 财政年份:
    2022
  • 资助金额:
    $ 28.45万
  • 项目类别:
    Discovery Grants Program - Individual
THE CONTROL OF TISSUE-SENSITIVITY TO AUTONOMIC AGENTS
组织对自主代理的敏感性的控制
  • 批准号:
    3255316
  • 财政年份:
    1978
  • 资助金额:
    $ 28.45万
  • 项目类别:
THE CONTROL OF TISSUE-SENSITIVITY TO AUTONOMIC AGENTS
组织对自主代理的敏感性的控制
  • 批准号:
    3255317
  • 财政年份:
    1978
  • 资助金额:
    $ 28.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了